Shelter Pharma Launches DB Cure Capsules To Strengthen Nutraceutical Portfolio

Shelter Pharma Ltd, a company rooted in natural healing practices since 1965, has unveiled DB Cure Capsules as part of its strategic expansion into the nutraceutical and preventive healthcare segment. The launch reflects the company’s commitment to diversifying beyond traditional pharmaceuticals and tapping into the fast-growing wellness market.  

Key highlights from the announcement include  

• DB Cure Capsules are formulated to prevent and treat Vitamin D deficiency, a widespread nutritional issue.  
• The product strengthens Shelter Pharma’s nutraceutical portfolio, aligning with its long-term growth strategy.  
• The launch supports the company’s vision of promoting preventive healthcare and wellness solutions.  
• Shelter Pharma has emphasized its focus on natural healing practices while integrating modern nutraceutical innovations.  
• Industry experts view this move as a significant step in positioning Shelter Pharma within the competitive wellness sector.  
• The company continues to expand its product base to cater to evolving consumer health needs.  

This development underscores Shelter Pharma’s proactive approach to addressing nutritional gaps and enhancing consumer well-being. By introducing DB Cure Capsules, the company is reinforcing its role in preventive healthcare while expanding its reach in the growing nutraceutical market.  

Sources: Business Upturn, ScanX News, BSE India Filing